Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Kai Pharmaceuticals Inc.

Headquarters: South San Francisco, CA, United States of America
Website: N/A
Year Founded: 2003
Status: Acquired

BioCentury | Apr 28, 2023
Management Tracks

Ball succeeds Maderis as CEO of Antiva

Plus: Valente joins Xencor and updates from Sutro, Gameto and more
BioCentury | Mar 18, 2020
Product Development

Bay Area labs pare down to essentials following shelter-in-place directives

COVID-19 makes Bay Area biotechs press pause on preclinical activities and band together
BioCentury | Nov 15, 2016
Clinical News

Parsabiv regulatory update

BioCentury | Sep 26, 2016
Clinical News

Parsabiv etelcalcetide regulatory update

BioCentury | Sep 5, 2016
Clinical News

Parsabiv etelcalcetide regulatory update

BioCentury | Jan 25, 2016
Clinical News

Etelcalcetide regulatory update

BioCentury | Nov 16, 2015
Clinical News

Etelcalcetide regulatory update

BioCentury | Sep 7, 2015
Clinical News

Etelcalcetide regulatory update

BioCentury | Mar 9, 2015
Finance

Column's creations

How The Column Group's long-term strategy yielded three wins
BioCentury | Mar 2, 2015
Clinical News

ONO-5163: Phase III data

Items per page:
1 - 10 of 58